InterpretOmics
Bangalore · Founded 2009
About InterpretOmics
InterpretOmics InterpretOmics is a integrated genomics company providing genome-scale data analysis and interpretation product and services for advancing healthcare, agriculture and energy. We are focused on deriving meaningful biological insights from complex multi-omics data for understanding human disease, crop disease and drug response. We utilize public and proprietary databases, advanced compute infrastructure and sophisticated algorithms to analyze data and interpret results. InterpretOmics is unique in having developed India's first enterprise class genomics data analysis platform iOMICS that allows to address the full spectrum of Next Generation Sequencing data challenges. Our services include analysis and interpretation of whole genome, transcriptome, exome, metagenome, epigenome and proteome data. We differ from other analysis platform and data analysis companies that have focused solely on providing compute and software infrastructure with data handling, believing that interpretation and mining for rare data points (outliers) offers the advantage of translating raw genomic data into meaningful scientific insights.
Company Facts
- Founded: 2009
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Angel (Aug 2013)
- Website: http://www.interpretomics.co
- Phone: +91 80 2521 2202
Industries & Categories
Analytics, Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/interpretomics-2867418 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.